Abstract:Objective To investigate the effect of N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) on mouse RAW264.7 macrophage cell line. Methods RAW264.7 mouse macrophage cells were cultured in vitro. Cells were divided into five groups,namely the control group (vehicle only),lipopolysaccharides (LPS) group (LPS only),and AcSDKP intervention groups (LPS plus AcSDKP at 1 nmol/L,10 nmol/L and 100 nmol/L). The mRNA levels of tumor necrosis factor-α (TNF-α),interleukin (IL)-1β,IL-6 and inducible nitric oxide synthase (iNOS) were measured by real-time RT-PCR. The chemotactic motility of RAW264.7 cells was detected by using Transwell assay. Western blot was performed to determine the iNOS,phosphorylated inhibitor of κB protein kinase complex (p-IKK),phosphorylated inhibitor of κB (p-IκB) and phosphorylated P65 (p-P65) expression. Results The mRNA levels of TNF-α,IL-1β and IL-6 in LPS group were increased by (41 ±2.1),(1073 ±80.8) and (1726 ±110.2) folds compared with in control group, respectively (P<0.01);the TNF-α mRNA levels in AcSDKP (1 nmol/L,10 nmol/L and 100 nmol/L) treatment groups were decreased by 8.1% (P>0.05), 19.0%(P<0.01) and 39.3%(P<0.01),respectively as compared with in LPS group,IL-1β were decreased by 22.0%,35.8% and 38.2%,respectively,(P<0.01),and IL-6 were decreased by 15.8%,35.7% and 43.3%, respectively (P<0.01);The migrated cell counts across the chamber membrane in LPS group (136±5.3)/HP were significantly higher than those in control group [(64±5.3),P<0.01],however,the cell counts in AcSDKP treatment groups [(105±4.8)/HP,(85.3±5.0)/HP and (73.7±5.6)/HP,P<0.05] were significantly lesser than those in LPS group (P<0.05);The mRNA and protein levels of iNOS were increased by (21 ±2.5) and (5.9 ±0.4) folds compared with those in the control group,However,the mRNA levels of iNOS in AcSDKP treatment groups were decreased by 37.8%,23.3% and 33.1%,respectively,and their protein levels were decreased by 27.0% and 40.2%(P<0.01)at the concentration of 10 nmol/L and 100 nmol/L of AcSDKP intervention;Relative levels of p-IKK,p-IκB and p-P65 protein in LPS group were increased by (25.9±4.8),(9.5±0.6) and (2.1±0.2) folds,respectively, as compared with those in control group;After AcSDKP (10 nmol/L) treatment,these protein levels were decreased by 42.5%(P<0.01),17.8%(P<0.05) and 29.7%(P<0.05),respectively,than those in cells treated with LPS alone. Conclusions AcSDKP exhibits a significant inhibitory effect on the proinflammatory profiles induced by LPS in mouse Raw264.7 macrophages in vitro,and this effect may be related to the blockage of the IKK/IκB/NF-κB signaling pathway.

The Anti-inflammatory Effect of the Benzoxazole Compound K310 on the LPS-stimulated RAW264.7 Macrophages

Effects of Salidroside on the Secretion of Inflammatory Mediators Induced by Lipopolysaccharide in Murine Macrophage Cell Line J774.1

K313, a Novel Benzoxazole Derivative, Exhibits Anti‐inflammatory Properties Via Inhibiting GSK3β Activity in LPS‐induced RAW264.7 Macrophages

Anti-inflammatory Effects of Ganoderma Lucidum Sterols Via Attenuation of the P38 MAPK and NF-κB Pathways in LPS-induced RAW 264.7 Macrophages

Benzoylaconine Modulates LPS-Induced Responses Through Inhibition of Toll-Like Receptor-Mediated NF-κB and MAPK Signaling in RAW264.7 Cells

The P38 MAPK Inhibitor JLU1124 Inhibits the Inflammatory Response Induced by Lipopolysaccharide Through the MAPK-NF-κB Pathway in RAW264.7 Macrophages.

Plantamajoside Ameliorates Lipopolysaccharide-Induced Acute Lung Injury Via Suppressing NF-κB and MAPK Activation.

Effects of Baimuxinol on the inflammation and oxidative stress of LPS-induced RAW264.7 macrophages via regulating the NF-κB/IκBα and Nrf2/ARE signaling pathway

The Anti-inflammatory Effects of 4-((5-Bromo-3-chloro-2-hydroxybenzyl) amino)-2-hydroxybenzoic Acid in Lipopolysaccharide-Activated Primary Microglial Cells

Stauntoside B inhibits macrophage activation by inhibiting NF-κB and ERK MAPK signalling.

Inhibitory effect of AcSDKP on the proinflammatory profiles induced by lipopolysaccharides in a mouse RAW264.7 macrophage cell line in vitro

Anti-inflammatory Effect of AMPK Activators from Natural Products in RAW 264.7 Cell Model (P06-095-19).

Discovery of an Effective Anti-Inflammatory Agent for Inhibiting the Activation of NF-κB

Ginsenoside Rk1 Suppresses Pro-Inflammatory Responses in Lipopolysaccharide-Stimulated Raw264.7 Cells by Inhibiting the Jak2/Stat3 Pathway

Anti-inflammatory effect of ozonated krill (Euphausia superba) oil in lipopolysaccharide-stimulated RAW 264.7 macrophages

Cell-free supernatant of Lactococcus lactis IDCC 2301 exerts anti-inflammatory effects in LPS-induced macrophages via NF-κB and MAPK signaling pathways

Effect of nitric oxide-releasing derivative of indomethacin on Prevotella intermedia lipopolysaccharide-induced production of proinflammatory mediators in murine macrophages

Investigation of the Anti-Inflammatory Activity of Fusaproliferin Analogues Guided by Transcriptome Analysis

Β‐carotene Attenuates Lipopolysaccharide‐induced Inflammation Via Inhibition of the NF‐κB, JAK2/STAT3 and JNK/p38 MAPK Signaling Pathways in Macrophages

Potential effect of astragaloside IV on the lipopolysaccharide induced inflammation via the inactivation of NF-κB signaling pathway

Anti-inflammatory Effect of a Limonin Derivative In Vivo and Its Mechanisms in RAW264.7 Cells